isofuranodiene has been researched along with cyclin d1 in 1 studies
| Studies (isofuranodiene) | Trials (isofuranodiene) | Recent Studies (post-2010) (isofuranodiene) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 42 | 0 | 32 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XP; Dang, YY; Lu, JJ; Wang, YT; Xu, WS | 1 |
1 other study(ies) available for isofuranodiene and cyclin d1
| Article | Year |
|---|---|
Furanodiene presents synergistic anti-proliferative activity with paclitaxel via altering cell cycle and integrin signaling in 95-D lung cancer cells.
Topics: Cell Cycle; Cell Line, Tumor; Curcuma; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinase 6; Drug Synergism; Drugs, Chinese Herbal; Endoplasmic Reticulum Stress; Focal Adhesion Kinase 1; Furans; Heterocyclic Compounds, 2-Ring; Humans; Integrin beta4; Lung Neoplasms; Paclitaxel; Paxillin; Proto-Oncogene Proteins c-myc; Signal Transduction | 2014 |